StockData
Unicycive Therapeutics, Inc. logo

Unicycive Therapeutics, Inc. (UNCY) stock

UNCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/30
$3.70+0.00 (0.00%)

Close on Nov 17, 2026Market cap $103.06MP/E –Yield –

Unicycive Therapeutics ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2022 it was -$17.62M.

Annual ebitda

PeriodPeriod endValueChange
FY2022Dec 31, 2022-$17.62M–
FY2021Dec 31, 2021-$8.51M–

More Unicycive Therapeutics figures

See a number that looks wrong?